4hha
From Proteopedia
(Difference between revisions)
(3 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
==Anti-Human Cytomegalovirus (HCMV) Fab KE5 with epitope peptide AD-2S1== | ==Anti-Human Cytomegalovirus (HCMV) Fab KE5 with epitope peptide AD-2S1== | ||
- | <StructureSection load='4hha' size='340' side='right' caption='[[4hha]], [[Resolution|resolution]] 1.60Å' scene=''> | + | <StructureSection load='4hha' size='340' side='right'caption='[[4hha]], [[Resolution|resolution]] 1.60Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[4hha]] is a 3 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4hha]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Human_betaherpesvirus_5 Human betaherpesvirus 5]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4HHA OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4HHA FirstGlance]. <br> |
- | </td></tr><tr id=' | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.6Å</td></tr> |
- | <tr id=' | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene></td></tr> |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4hha FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4hha OCA], [https://pdbe.org/4hha PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4hha RCSB], [https://www.ebi.ac.uk/pdbsum/4hha PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4hha ProSAT]</span></td></tr> |
</table> | </table> | ||
+ | == Function == | ||
+ | [https://www.uniprot.org/uniprot/Q9YKI2_HCMV Q9YKI2_HCMV] | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | The human Ab response to certain pathogens is oligoclonal, with preferred IgV genes being used more frequently than others. A pair of such preferred genes, IGVK3-11 and IGVH3-30, contributes to the generation of protective Abs directed against the 23F serotype of the pneumonococcal capsular polysaccharide of Streptococcus pneumoniae and against the AD-2S1 peptide of the gB membrane protein of human CMV. Structural analyses of Fab fragments of mAbs 023.102 and pn132p2C05 in complex with portions of the 23F polysaccharide revealed five germline-encoded residues in contact with the key component, l-rhamnose. In the case of the AD-2S1 peptide, the KE5 Fab fragment complex identified nine germline-encoded contact residues. Two of these germline-encoded residues, Arg91L and Trp94L, contact both the l-rhamnose and the AD-2S1 peptide. Comparison of the respective paratopes that bind to carbohydrate and protein reveals that stochastic diversity in both CDR3 loops alone almost exclusively accounts for their divergent specificity. Combined evolutionary pressure by human CMV and the 23F serotype of S. pneumoniae acted on the IGVK3-11 and IGVH3-30 genes as demonstrated by the multiple germline-encoded amino acids that contact both l-rhamnose and AD-2S1 peptide. | ||
+ | |||
+ | Structures of Preferred Human IgV Genes-Based Protective Antibodies Identify How Conserved Residues Contact Diverse Antigens and Assign Source of Specificity to CDR3 Loop Variation.,Bryson S, Thomson CA, Risnes LF, Dasgupta S, Smith K, Schrader JW, Pai EF J Immunol. 2016 Jun 1;196(11):4723-30. doi: 10.4049/jimmunol.1402890. Epub 2016, Apr 29. PMID:27183571<ref>PMID:27183571</ref> | ||
+ | |||
+ | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
+ | </div> | ||
+ | <div class="pdbe-citations 4hha" style="background-color:#fffaf0;"></div> | ||
==See Also== | ==See Also== | ||
- | *[[3D structures of | + | *[[Antibody 3D structures|Antibody 3D structures]] |
+ | *[[Monoclonal Antibodies 3D structures|Monoclonal Antibodies 3D structures]] | ||
+ | *[[3D structures of human antibody|3D structures of human antibody]] | ||
+ | == References == | ||
+ | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
- | [[Category: | + | [[Category: Human betaherpesvirus 5]] |
- | [[Category: | + | [[Category: Large Structures]] |
- | [[Category: | + | [[Category: Bryson S]] |
- | [[Category: | + | [[Category: Damgupta S]] |
- | [[Category: | + | [[Category: Pai EF]] |
- | [[Category: | + | [[Category: Pfoh R]] |
- | [[Category: | + | [[Category: Risnes L]] |
- | [[Category: | + | [[Category: Schrader JW]] |
- | [[Category: | + | [[Category: Thomson CA]] |
- | + |
Current revision
Anti-Human Cytomegalovirus (HCMV) Fab KE5 with epitope peptide AD-2S1
|